The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation.
The emergence of the novel 2009 H1N1 influenza virus highlights unique aspects of transplant care that will require heightened vigilance in coming months. Recognition of the syndrome, aggressive diagnosis and early treatment should be paired with active preventative measures to stem the impact of infection in the transplant population. This special advisory addresses issues relevant to cardiothoracic transplant candidates, selection of donors, recipient management and those patients with mechanical circulatory support devices.
Danziger-Isakov
Lara A
LA
Department of Pediatrics, Cleveland Clinic Children's Hospital, Cleveland, OH 44195, USA. danzigl@ccf.org
Husain
Shahid
S
Mooney
Martha L
ML
Hannan
Margaret M
MM
D004196:Disease Outbreaks / Q000517:prevention & control* / Q000706:statistics & numerical data; D014943:Global Health; D016041:Heart-Lung Transplantation; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D009313:National Health Programs / Q000458:organization & administration*; D014611:Vaccination / Q000379:methods